Bio-Techne

TECH • NASDAQ • Stock Fundamentals

Bio-Techne is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kim Kelderman, with a market cap of $8.5B.

Market Cap$8.5B

Employees3.1K

CEOKim Kelderman

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ3 2026

Next EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q4 2026

Financials

Based on Q3 2026 filing

TEC

Common questions about Bio-Techne

Bio-Techne (TECH) has a market capitalization of $8.5B and trades on NASDAQ.

Bio-Techne has approximately 3,050 employees.